Publications by authors named "Richard Pushkin"

Claim this Profile
F
First-in-human study of TN-201, an AAV9 gene replacement therapy in MYBPC3-associated hypertrophic cardiomyopathy: initial safety, pharmacodynamic, and imaging results from MyPEAK-1.
Milind Y Desai, Sherif F Nagueh, John R Giudicessi, Michael J Previs, Danielle Kellner, Richard Pushkin

Cardiovasc Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Study Evaluating Oral Fusidic Acid (CEM-102) in Combination With Oral Rifampin Compared With Standard-of-Care Antibiotics for Treatment of Prosthetic Joint Infections: A Newly Identified Drug-Drug Interaction.
Richard Pushkin, Maria D Iglesias-Ussel, Kara Keedy, Chris MacLauchlin, Diane R Mould

Clin Infect Dis· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Penetration of Ceftaroline into the Epithelial Lining Fluid of Healthy Adult Subjects.
Todd A Riccobene, Richard Pushkin, Alena Jandourek, William Knebel, Tatiana Khariton

Antimicrob Agents Chemother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telavancin for Acute Bacterial Skin and Skin Structure Infections, a Post Hoc Analysis of the Phase 3 ATLAS Trials in Light of the 2013 FDA Guidance.
Richard Pushkin, Steven L Barriere, Whedy Wang, G Ralph Corey, Martin E Stryjewski

Antimicrob Agents Chemother· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the reporting of adverse drug reactions in the hospital setting.
Richard Pushkin, Lynda Frassetto, Candy Tsourounis, Eleanor S Segal, Stephanie Kim

Postgrad Med· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis